The efficacy and safety of donor lymphocyte infusions for the treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation for a phase 2 multi-center clinical trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 5c34873fc602fb5527badd5db93c42558b032ac6
First added on: Apr 08, 2025